Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07436156 · ClinicalTrials.gov registry record · Phase 4
SUMMIT RISE Study of Acute Ischemic Stroke Patients
A Phase 4 study of Acute Ischemic Stroke, sponsored by Route 92 Medical.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 500
- Enrollment target
- 1
- Study location
NCT07436156: Recruiting Phase 4 study of Acute Ischemic Stroke, sponsored by Route 92 Medical.
NCT07436156 is a Phase 4 study of Acute Ischemic Stroke that is actively recruiting participants, run by Route 92 Medical. The registered enrollment target is 500 participants, above the 332-participant average among 25 other Acute Ischemic Stroke trials with a reported enrollment target (51% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07436156, a Phase 4 study of Acute Ischemic Stroke, is actively recruiting participants, sponsored by Route 92 Medical.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 500 participants
- Enrollment target
- 1
- Study location
Study Summary
SUMMIT RISE Study of Acute Ischemic Stroke Patients
Primary Outcome
Revascularization status checklist
Conditions Studied
Interventions
- DEVICE Route 92 Medical Reperfusion Systems
Study Locations (1)
Utah
- Route 92 Medical, Inc. - West Jordan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2026-02-12 |
| Est. Completion | 2029-11-30 |
| Phase | Phase 4 |
What NCT07436156 shows while recruiting
NCT07436156 is an interventional study that assigns participants to a tested intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap, above the 332-participant average among 25 other Acute Ischemic Stroke trials with a reported enrollment target (51% higher).
The record links to 1 condition, with Acute Ischemic Stroke appearing as the primary indexed condition, and to 1 intervention - of which Route 92 Medical Reperfusion Systems is the first listed.
NCT07436156 reports a single indexed study location in Utah.
Frequently Asked Questions
What is clinical trial NCT07436156 about?
NCT07436156 is a clinical study titled "SUMMIT RISE Study of Acute Ischemic Stroke Patients". SUMMIT RISE Study of Acute Ischemic Stroke Patients
What is the current status of trial NCT07436156?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 500 participants. The study started on 2026-02-12. Estimated completion is 2029-11-30.
What conditions does trial NCT07436156 study?
This clinical trial studies the following conditions: Acute Ischemic Stroke.
What interventions are being tested in trial NCT07436156?
The interventions under investigation include: Route 92 Medical Reperfusion Systems (DEVICE).
Who is sponsoring clinical trial NCT07436156?
This trial is sponsored by Route 92 Medical, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07436156 being conducted?
This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Ischemic Stroke
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07436156's enrollment target sits among peer trials
500 9th of 25 higher than 17 of 25 other Acute Ischemic Stroke trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Acute Ischemic Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Transcranial Direct Current Stimulation for Treatment of Acute Ischemic Stroke
RECRUITING · Phase 2
-
Non-invasive Vagus Nerve Stimulation to Reduce Inflammation and Brain Injury Blood Biomarkers Following an Acute Ischemic Stroke
RECRUITING · NA
-
Proximal Internal Carotid Artery Acute Stroke Secondary to Tandem or Local Occlusion Thrombectomy Trial
RECRUITING · Phase 3
-
Optimizing Reperfusion to Improve Outcomes and Neurologic Function
RECRUITING · Phase 2
-
Blood Pressure Variability and Ischemic Stroke Outcome
RECRUITING
-
Hyperbaric Oxygen Therapy in Acute Ischemic Stroke Ischemic Stroke Recovery (Pro00061930)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI